Block listing Interim Review

RNS Number : 1186I
Circassia Pharmaceuticals Plc
31 March 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 31st March 2020

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia EMI Share Option Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

700,750

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

700,750

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2007 Unapproved Share Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

203,000

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

203,000

 



 

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2014 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

76,676

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

76,676

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2015 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

280,612

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(4,442)

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

276,170

 



 

 

Name of applicant:

Circassia Pharmaceuticals plc

Name of scheme:

Circassia 2016 Performance Share Plan Scheme

Period of return:

From:

1st October 2019

To:

31st March 2020

Balance of unallotted securities under scheme(s) from previous return:

812,071

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less:   Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(26,902)

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

785,169

 

 

 

Name of contact:

Michael Roller

Telephone number of contact:

01865 405 560

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRWPUCGWUPUGQU

Companies

Niox Group (NIOX)
UK 100

Latest directors dealings